Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against  Myriad Genetics, Inc. OKLAHOMA CITY, April 23, 2018 (GLOBE NEWSWIRE) -- Federman & Sherwood announces that on April 20, 2018, a class action lawsuit was filed in the United States District Court for the District of...

Myriad Pharmaceuticals, Inc. Established as an Independent Pharmaceutical Development Company Company Will Advance Three Clinical Development Programs in Oncology and Infectious Disease Conference Call Scheduled for 10:00 AM EDT On July 1,...

Myriad Pharmaceuticals, Inc. to Host Initial Public Conference Call On July 1, 2009 SALT LAKE CITY, June 29, 2009 (GLOBE NEWSWIRE) -- Myriad Pharmaceuticals, Inc. (Nasdaq:MYRXV) today announced that it will hold a live webcast on Wednesday, July 1, 2009 at 10:00 AM EDT. Adrian...